
Haemonetics Corp (HAE)
NYSE
Fin d'année 30 Mars 2024 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Return on Assets (%) | -2.054 | 3.681 | 4.38 | 6.021 | 5.149 | 2.358 | 6.082 | 5.692 |
Return on Equity (%) | -3.595 | 6.109 | 7.748 | 12.196 | 12.052 | 5.857 | 14.725 | 13.224 |
Return on Invested Capital (%) | 7.927 | 7.994 | 12.693 | 17.593 | 15.052 | 6.906 | 12.094 | 12.412 |
Operating Margin (%) | -3.101 | 7.098 | 7.61 | 8.817 | 8.376 | 8.13 | 13.351 | 12.596 |
Net Profit Margin (%) | -2.964 | 5.042 | 5.686 | 7.742 | 9.13 | 4.367 | 9.875 | 8.98 |
Book Value Per Share | 6.721 | 7.345 | 6.455 | 4.836 | -1.971 | -0.55 | 1.507 | -0.221 |
Earnings Per Share | -0.503 | 0.871 | 1.078 | 1.521 | 1.562 | 0.848 | 2.288 | 2.315 |
Cash Per Share | 2.671 | 3.442 | 3.319 | 2.729 | 3.78 | 5.076 | 5.639 | 3.521 |
Working Capital Per Share | 5.719 | 2.607 | 6.671 | 6.534 | 8.651 | 6.137 | 10.267 | 9.225 |
Operating Profit Per Share | 9.276 | 9.616 | 10.356 | 11.83 | 9.477 | 11.988 | 13.396 | 15.123 |
EBIT Per Share | -0.526 | 1.139 | 1.443 | 1.732 | 1.433 | 1.245 | 2.803 | 2.99 |
EBITDA Per Share | -0.526 | 1.139 | 1.443 | 1.732 | 1.433 | 1.245 | 2.803 | 2.99 |
Free Cash Flow Per Share | -0.763 | 0.595 | 1.265 | 0.298 | 0.633 | -0.103 | 2.622 | 1.706 |
Fin d'année 30 Mars 2024 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Actions en circulation | 52,26M | 52,34M | 51,02M | 50,32M | 50,87M | 51,12M | N/A | N/A |
Fin d'année 30 Mars 2024 | Avr 2023 | Juil 2023 | Sept 2023 | Déc 2023 | Mar 2024 | Juin 2024 | Sept 2024 | Déc 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Actions en circulation | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Margin (%) | N/A | 17.235 | N/A | N/A | N/A | 13.896 | N/A | N/A |
Net Profit Margin (%) | N/A | 13.183 | N/A | N/A | N/A | 11.415 | N/A | N/A |
Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Capitalisation boursière | 2,87B |
Ratio cours/bénéfice | 24,1 |
Ratio prix/ventes | 2,16 |
Ratio prix/liquidités | 15,85 |
Ratio prix/valeur comptable | 2,95 |
Rendement de dividende | - |
Actions en circulation | 50,24M |
Volume moyen (1 semaine) | 590,72k |
Volume moyen (1 mois) | 746,09k |
Variation sur 52 semaines | -30,67% |
Plus haut sur 52 semaines | 97,97 |
Plus bas sur 52 semaines | 55,23 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales